A new classification for malignant lymphomas aids in identifying patient groups for therapeutic trials. This system integrates immunologic and morphologic data, refining the Working Formulation for primary cutaneous lymphomas.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: